11 July 2019
3DMedLIVE announces programme and first confirmed speakers
The programme and first confirmed speakers for event, 3DMedLIVE 2019: 3D printing in surgery, have been announced, boasting international key opinion leaders in medical 3D printing, engineering and surgical regulation.
The programme and first confirmed speakers for 3DMedLIVE 2019: 3D printing in surgery have been announced, in conjunction with accreditation from the Royal College of Surgeons of England for up to 10.5 CPD points.
Held in London (UK) on 2–3 October 2019 and hosted by Future Science Group eCommunity, 3DMedNet, 3DMedLIVE: 3D printing in surgery aims to convene a community of innovation and best practice to advance surgical applications of 3D printing.
Boasting an impressive international conference Advisory Board and support from a number of prestigious media and commercial partners, 3DMedLIVE serves as a platform for the presentation and discussion of innovation in the healthcare industry, supported by a multidisciplinary and collaborative community.
“The 3DMedLIVE conference will be an excellent platform to demonstrate that 3D printing technology enables more effective patient consultations, increases diagnostic quality, improves surgical planning, acts as an orientation aid during surgery and provides a template for surgical resection,” Dietmar Hutmacher, Editor-in-Chief of supporting journal, the Journal of 3D Printing in Medicine, explained.
The recently released programme includes discussion of topics surrounding the Future of Surgery and NHS Long Term Plan, questions regarding the regulation of 3D printed medical devices at present as well as in the near future, and even includes the subject of augmented reality and 3D technology in developing world surgery.
The full programme has also allocated space to case study presentations from surgeons and thought leaders in medical 3D printing supporting discussions with real world case studies and inspiration for innovative use of 3D technologies in medicine.
“The conference will involve leaders in the field presenting on how todays 3D printing technology has the potential to be very valuable to clinicians for delivering and performing patient-specific individualized surgery,” Hutmacher continued.
Key leaders already confirmed to be speaking at the event include:
Richard Kerr, Chair of the Commission on the Future of Surgery with the Royal College of Surgeons (London, UK)
Carol Read, Clinical Innovation Manager (Salisbury NHS Foundation Trust, UK)
David Dunaway, Professor of Craniofacial Surgery (Institute of Child Health, Great Ormond Street and University College London; UK)
Adrian Sugar, Chair of the Centre for Applied Reconstructive Technologies in Surgery (Cardiff, UK)
Nadine Hachach-Haram, Co-founder (Proximie; London, UK)
Amie Smirthwaite, Global Head of Clinical Compliance (BSI; London, UK)
Amy Alexander, Senior Biomedical Engineer (Mayo Clinic; MI, USA)
"The 2019 3DMedLIVE event is an opportunity for specialists in 3D medicine from a variety of backgrounds to discuss the progression of the field. The international meeting leverages the intersection of advanced medical imaging, personalized surgery, modern data analytics, revolutionary digital design, and innovative engineering. This particular type of in-person collaboration leads to thoughtful innovation and deliberate advancement," Amy Alexander added.
Georgi Makin, Editor of host website, 3DMedNet, concluded: “I am looking forward to the opportunity to see the community surrounding 3DMedNet brought to life at 3DMedLIVE, as we bring together surgeons, regulators, engineers, funders and representatives from industry to take 3D printing in surgery to the next level, together.”
For more information on how to partner with 3DMedLIVE, contact Business Development Director, Sarah Mayes, via email at email@example.com
About Future Science Group
Founded in 2001, Future Science Group is a progressive publisher focused on breakthrough medical, biotechnological and scientific research.
Future Science Group’s portfolio consists of three publishing imprints, Future Science, Future Medicine, Newlands Press, as well as a content development imprint, PharmaPlatforms. In addition to a core business of subscription and open access journal publishing, Future Science Group develops specialist knowledge networks and content hubs, enabling professionals to easily connect and collaborate with their peers in niche scientific fields.
The aim of Future Science Group is to serve the advancement of clinical practice and drug research by enhancing the efficiency of communication among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs.
This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.